Tylvalosin Tartrate Premix
- Createtime： 2023-03-24
- Updatetime： 2023-03-24
Brand name: Shengxue Taikes
Common name: Tylvalosin tartrate premix
Main ingredient: Tylvalosin tartrate
Characteristics: This product is a light yellow-brown or yellow-brown powder.
Specification: 100g: 20g (20 million units)
Tylvalosin tartrate has good cell membrane permeability and strong affinity for the 70S ribosome of bacteria, which can inhibit bacterial protein synthesis and thus inhibit bacterial proliferation. Tylvalosin tartrate has antibacterial activity against Gram-positive bacteria, and is effective against Gram-positive bacteria resistant to other antibiotics, but almost ineffective against Gram-negative bacteria. Tylvalosin tartrate has strong antibacterial activity against mycoplasma and pleuropneumonia-like organisms.
Indications and Usage: Used for mycoplasma infection in pigs and mycoplasma infection in chickens.
Introduction to Tylvalosin Tartrate Premix
Tylvalosin tartrate premix is a veterinary medication that belongs to the class of macrolide antibiotics. It is used for the prevention and treatment of respiratory tract infections in pigs, poultry, and other farm animals caused by certain bacteria, including Mycoplasma spp. and Pasteurella spp. Tylvalosin tartrate premix is available as a premix powder that can be added to the animal feed, making it a convenient and effective way to deliver the medication to large groups of animals.
Tylvalosin tartrate premix is indicated for the prevention and treatment of respiratory tract infections in livestock caused by the following bacteria:
Tylvalosin tartrate premix is effective in controlling and preventing swine respiratory disease complex (SRDC), enzootic pneumonia, and chronic respiratory disease in poultry.
Dosage and Administration
The recommended dosage of tylvalosin tartrate premix is 25-50 mg/kg body weight per day, given orally, mixed into the animal feed, for a period of 3-7 days. The premix can be added to the feed at a rate of 100-200 g per ton of feed, depending on the animal species, age, and weight. The medicated feed should be the only source of feed during the treatment period.
Tylvalosin tartrate premix should not be given to animals with a known hypersensitivity to macrolide antibiotics or any of the other ingredients in the medication. It should not be used in animals intended for human consumption. The medication should not be used concurrently with other macrolide antibiotics or ionophore coccidiostats.
The most common side effects of tylvalosin tartrate premix include:
Gastrointestinal disturbances, such as diarrhea, vomiting, and decreased appetite
Irritation and inflammation of the digestive tract
Allergic reactions, such as skin rash or hives
In rare cases, the medication can cause more serious side effects, such as liver damage or anaphylaxis. If an animal experiences any unusual symptoms, immediate veterinary attention is required.
Tylvalosin tartrate premix should be handled with care and kept out of reach of children. It should be stored in a cool, dry place and protected from light. The medication should not be used past the expiration date printed on the packaging.
The medication should be used with caution in pregnant and lactating animals, as the safety of the medication in these animals has not been established.
Tylvalosin tartrate premix is an effective medication for the prevention and treatment of respiratory tract infections in livestock caused by certain bacteria. Its ease of administration and broad-spectrum activity make it a valuable tool in the management of respiratory disease. However, as with any medication, it should be used with caution and only under the guidance of a veterinarian. Regular monitoring of animals receiving tylvalosin tartrate is necessary to detect and manage any adverse effects.